The reduction of adiponectin seems to have a major impact on the development of hepatic steatosis and NASH caused by its direct antagonistic effect on TNFα, one of the most important cytokines in mediating inflammation. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.